Annual SG&A
$11.44 M
+$714.00 K+6.66%
31 December 2023
Summary:
Achieve Life Sciences annual selling, general & administrative expenses is currently $11.44 million, with the most recent change of +$714.00 thousand (+6.66%) on 31 December 2023. During the last 3 years, it has risen by +$3.57 million (+45.35%). ACHV annual SG&A is now -3.13% below its all-time high of $11.80 million, reached on 31 December 2015.ACHV Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.86 M
+$1.54 M+46.38%
30 September 2024
Summary:
Achieve Life Sciences quarterly selling, general & administrative expenses is currently $4.86 million, with the most recent change of +$1.54 million (+46.38%) on 30 September 2024. Over the past year, it has increased by +$1.87 million (+62.39%). ACHV quarterly SG&A is now at all-time high.ACHV Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$711.92 M
-$32.94 M-4.85%
30 September 2024
Summary:
Achieve Life Sciences TTM selling, general & administrative expenses is currently -$711.92 million, with the most recent change of -$32.94 million (-4.85%) on 30 September 2024. Over the past year, it has dropped by -$723.33 million (-6338.35%). ACHV TTM SG&A is now -5334.50% below its all-time high of $13.63 million, reached on 30 September 2024.ACHV TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | +62.4% | -6338.4% |
| 3 y3 years | +45.4% | +131.1% | -8105.4% |
| 5 y5 years | +64.7% | +156.6% | -10000.0% |
ACHV Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +45.4% | at high | +131.1% | -141.3% | at low |
| 5 y | 5 years | at high | +66.8% | at high | +235.9% | -415.8% | at low |
| alltime | all time | -3.1% | +700.8% | at high | +193.2% | -5334.5% | +3.3% |
Achieve Life Sciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.86 M(+46.4%) | $13.63 M(+15.9%) |
| June 2024 | - | $3.32 M(+4.2%) | $11.76 M(+1.6%) |
| Mar 2024 | - | $3.18 M(+40.1%) | $11.57 M(+1.2%) |
| Dec 2023 | $11.44 M(+6.7%) | $2.27 M(-24.0%) | $11.44 M(+0.2%) |
| Sept 2023 | - | $2.99 M(-4.4%) | $11.41 M(+2.0%) |
| June 2023 | - | $3.13 M(+2.8%) | $11.19 M(+2.4%) |
| Mar 2023 | - | $3.04 M(+35.4%) | $10.93 M(+1.9%) |
| Dec 2022 | $10.72 M(+17.5%) | $2.25 M(-18.8%) | $10.72 M(-3.3%) |
| Sept 2022 | - | $2.77 M(-3.3%) | $11.08 M(+6.4%) |
| June 2022 | - | $2.87 M(+1.0%) | $10.41 M(+8.2%) |
| Mar 2022 | - | $2.84 M(+8.8%) | $9.62 M(+5.4%) |
| Dec 2021 | $9.13 M(+16.0%) | $2.61 M(+24.1%) | $9.13 M(+2.6%) |
| Sept 2021 | - | $2.10 M(+1.3%) | $8.89 M(+2.8%) |
| June 2021 | - | $2.08 M(-11.4%) | $8.65 M(+3.1%) |
| Mar 2021 | - | $2.34 M(-1.3%) | $8.39 M(+6.7%) |
| Dec 2020 | $7.87 M(+14.8%) | $2.37 M(+27.4%) | $7.87 M(+13.4%) |
| Sept 2020 | - | $1.86 M(+2.6%) | $6.94 M(-0.4%) |
| June 2020 | - | $1.81 M(-0.1%) | $6.97 M(+2.7%) |
| Mar 2020 | - | $1.82 M(+25.6%) | $6.79 M(-1.0%) |
| Dec 2019 | $6.85 M(-1.3%) | $1.45 M(-23.6%) | $6.85 M(-2.6%) |
| Sept 2019 | - | $1.89 M(+16.1%) | $7.04 M(+2.0%) |
| June 2019 | - | $1.63 M(-13.5%) | $6.90 M(-1.7%) |
| Mar 2019 | - | $1.89 M(+15.8%) | $7.02 M(+1.0%) |
| Dec 2018 | $6.95 M(+96.7%) | $1.63 M(-7.1%) | $6.95 M(-0.0%) |
| Sept 2018 | - | $1.75 M(+0.1%) | $6.95 M(+3.0%) |
| June 2018 | - | $1.75 M(-3.4%) | $6.74 M(+32.6%) |
| Mar 2018 | - | $1.81 M(+11.3%) | $5.08 M(+44.0%) |
| Dec 2017 | $3.53 M(+147.3%) | $1.63 M(+5.1%) | $3.53 M(-206.8%) |
| Sept 2017 | - | $1.55 M(+1566.7%) | -$3.31 M(+10.5%) |
| June 2017 | - | $93.00 K(-64.2%) | -$2.99 M(+389.9%) |
| Mar 2017 | - | $260.00 K(-105.0%) | -$611.00 K(-142.8%) |
| Dec 2016 | $1.43 M(-87.9%) | -$5.21 M(-379.5%) | $1.43 M(-85.1%) |
| Sept 2016 | - | $1.86 M(-24.7%) | $9.55 M(-11.7%) |
| June 2016 | - | $2.48 M(+7.7%) | $10.81 M(-5.2%) |
| Mar 2016 | - | $2.30 M(-21.1%) | $11.41 M(-3.4%) |
| Dec 2015 | $11.80 M(+11.1%) | $2.92 M(-6.7%) | $11.80 M(+1.6%) |
| Sept 2015 | - | $3.13 M(+1.9%) | $11.62 M(+6.1%) |
| June 2015 | - | $3.07 M(+13.7%) | $10.96 M(+3.7%) |
| Mar 2015 | - | $2.70 M(-1.3%) | $10.57 M(-0.6%) |
| Dec 2014 | $10.63 M(+7.4%) | $2.73 M(+11.1%) | $10.63 M(+2.8%) |
| Sept 2014 | - | $2.46 M(-8.1%) | $10.34 M(-0.1%) |
| June 2014 | - | $2.68 M(-2.9%) | $10.35 M(+2.0%) |
| Mar 2014 | - | $2.76 M(+12.7%) | $10.15 M(+2.6%) |
| Dec 2013 | $9.89 M(+27.0%) | $2.45 M(-1.1%) | $9.89 M(+4.3%) |
| Sept 2013 | - | $2.47 M(0.0%) | $9.49 M(+5.7%) |
| June 2013 | - | $2.47 M(-1.1%) | $8.98 M(+5.0%) |
| Mar 2013 | - | $2.50 M(+22.4%) | $8.55 M(+9.8%) |
| Dec 2012 | $7.79 M(+25.1%) | $2.04 M(+3.9%) | $7.79 M(+4.2%) |
| Sept 2012 | - | $1.97 M(-4.0%) | $7.48 M(+7.3%) |
| June 2012 | - | $2.05 M(+17.8%) | $6.97 M(+9.0%) |
| Mar 2012 | - | $1.74 M(+0.3%) | $6.40 M(+2.7%) |
| Dec 2011 | $6.23 M(+6.7%) | $1.73 M(+18.8%) | $6.23 M(-3.4%) |
| Sept 2011 | - | $1.46 M(-1.0%) | $6.45 M(+6.4%) |
| June 2011 | - | $1.47 M(-6.4%) | $6.06 M(-0.1%) |
| Mar 2011 | - | $1.57 M(-19.4%) | $6.06 M(+3.8%) |
| Dec 2010 | $5.84 M(+47.4%) | $1.95 M(+82.6%) | $5.84 M(+12.7%) |
| Sept 2010 | - | $1.07 M(-27.7%) | $5.18 M(+3.6%) |
| June 2010 | - | $1.48 M(+9.3%) | $5.00 M(+10.4%) |
| Mar 2010 | - | $1.35 M(+4.6%) | $4.53 M(+14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $3.96 M(+20.3%) | $1.29 M(+45.9%) | $3.96 M(+6.5%) |
| Sept 2009 | - | $885.00 K(-11.8%) | $3.72 M(-3.6%) |
| June 2009 | - | $1.00 M(+28.3%) | $3.86 M(-28.0%) |
| Mar 2009 | - | $782.00 K(-25.5%) | $5.36 M(-19.7%) |
| Dec 2008 | $3.29 M(-59.9%) | $1.05 M(+2.5%) | $6.68 M(-18.4%) |
| Sept 2008 | - | $1.02 M(-59.2%) | $8.19 M(-6.2%) |
| June 2008 | - | $2.51 M(+19.3%) | $8.72 M(+4.5%) |
| Mar 2008 | - | $2.10 M(-17.7%) | $8.34 M(+1.5%) |
| Dec 2007 | $8.22 M(+8.5%) | $2.55 M(+63.4%) | $8.22 M(+5.4%) |
| Sept 2007 | - | $1.56 M(-26.6%) | $7.80 M(-2.8%) |
| June 2007 | - | $2.13 M(+7.7%) | $8.02 M(+3.1%) |
| Mar 2007 | - | $1.98 M(-7.4%) | $7.78 M(+2.7%) |
| Dec 2006 | $7.58 M(+36.0%) | $2.13 M(+19.5%) | $7.58 M(+9.6%) |
| Sept 2006 | - | $1.79 M(-5.4%) | $6.91 M(+11.7%) |
| June 2006 | - | $1.89 M(+6.7%) | $6.19 M(+10.6%) |
| Mar 2006 | - | $1.77 M(+20.5%) | $5.60 M(+0.5%) |
| Dec 2005 | $5.57 M(-5.1%) | $1.47 M(+38.0%) | $5.57 M(-14.0%) |
| Sept 2005 | - | $1.06 M(-17.9%) | $6.48 M(-3.4%) |
| June 2005 | - | $1.30 M(-25.7%) | $6.71 M(+2.1%) |
| Mar 2005 | - | $1.74 M(-26.6%) | $6.57 M(+11.9%) |
| Dec 2004 | $5.87 M(+95.0%) | $2.38 M(+84.0%) | $5.87 M(+37.6%) |
| Sept 2004 | - | $1.29 M(+11.6%) | $4.26 M(+15.8%) |
| June 2004 | - | $1.16 M(+10.6%) | $3.68 M(+10.7%) |
| Mar 2004 | - | $1.05 M(+35.7%) | $3.33 M(+10.6%) |
| Dec 2003 | $3.01 M(-7.2%) | $771.00 K(+8.7%) | $3.01 M(+1.4%) |
| Sept 2003 | - | $709.00 K(-11.6%) | $2.97 M(-2.5%) |
| June 2003 | - | $802.20 K(+10.3%) | $3.05 M(-1.9%) |
| Mar 2003 | - | $727.50 K(-0.4%) | $3.10 M(-4.2%) |
| Dec 2002 | $3.24 M(-2.1%) | $730.30 K(-7.1%) | $3.24 M(-2.7%) |
| Sept 2002 | - | $785.70 K(-8.8%) | $3.33 M(-10.5%) |
| June 2002 | - | $861.10 K(-0.5%) | $3.72 M(+7.1%) |
| Mar 2002 | - | $865.10 K(+5.3%) | $3.48 M(+5.1%) |
| Dec 2001 | $3.31 M(-24.5%) | $821.20 K(-30.2%) | $3.31 M(-0.3%) |
| Sept 2001 | - | $1.18 M(+91.1%) | $3.32 M(+4.7%) |
| June 2001 | - | $615.80 K(-11.6%) | $3.17 M(-14.1%) |
| Mar 2001 | - | $696.70 K(-16.3%) | $3.69 M(-15.7%) |
| Dec 2000 | $4.38 M(-32.6%) | $832.60 K(-19.1%) | $4.38 M(-3.7%) |
| Sept 2000 | - | $1.03 M(-9.5%) | $4.55 M(-16.3%) |
| June 2000 | - | $1.14 M(-18.0%) | $5.44 M(-12.3%) |
| Mar 2000 | - | $1.39 M(+38.2%) | $6.20 M(-4.8%) |
| Dec 1999 | $6.50 M(-0.7%) | $1.00 M(-47.7%) | $6.52 M(-2.2%) |
| Sept 1999 | - | $1.92 M(+0.8%) | $6.66 M(+0.2%) |
| June 1999 | - | $1.90 M(+11.8%) | $6.65 M(+1.5%) |
| Mar 1999 | - | $1.70 M(+48.0%) | $6.55 M(0.0%) |
| Dec 1998 | $6.55 M(-9.0%) | $1.15 M(-39.5%) | $6.55 M(-13.8%) |
| Sept 1998 | - | $1.90 M(+5.6%) | $7.60 M(-3.8%) |
| June 1998 | - | $1.80 M(+5.9%) | $7.90 M(+2.6%) |
| Mar 1998 | - | $1.70 M(-22.7%) | $7.70 M(+6.9%) |
| Dec 1997 | $7.20 M(+89.5%) | $2.20 M(0.0%) | $7.20 M(+18.0%) |
| Sept 1997 | - | $2.20 M(+37.5%) | $6.10 M(+27.1%) |
| June 1997 | - | $1.60 M(+33.3%) | $4.80 M(+20.0%) |
| Mar 1997 | - | $1.20 M(+9.1%) | $4.00 M(+8.1%) |
| Dec 1996 | $3.80 M(+72.7%) | $1.10 M(+22.2%) | $3.70 M(+19.4%) |
| Sept 1996 | - | $900.00 K(+12.5%) | $3.10 M(+14.8%) |
| June 1996 | - | $800.00 K(-11.1%) | $2.70 M(+42.1%) |
| Mar 1996 | - | $900.00 K(+80.0%) | $1.90 M(+90.0%) |
| Dec 1995 | $2.20 M(-37.1%) | $500.00 K(0.0%) | $1.00 M(+100.0%) |
| Sept 1995 | - | $500.00 K | $500.00 K |
| Dec 1994 | $3.50 M | - | - |
FAQ
- What is Achieve Life Sciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Achieve Life Sciences?
- What is Achieve Life Sciences annual SG&A year-on-year change?
- What is Achieve Life Sciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly SG&A year-on-year change?
- What is Achieve Life Sciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Achieve Life Sciences?
- What is Achieve Life Sciences TTM SG&A year-on-year change?
What is Achieve Life Sciences annual selling, general & administrative expenses?
The current annual SG&A of ACHV is $11.44 M
What is the all time high annual SG&A for Achieve Life Sciences?
Achieve Life Sciences all-time high annual selling, general & administrative expenses is $11.80 M
What is Achieve Life Sciences annual SG&A year-on-year change?
Over the past year, ACHV annual selling, general & administrative expenses has changed by +$714.00 K (+6.66%)
What is Achieve Life Sciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of ACHV is $4.86 M
What is the all time high quarterly SG&A for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly selling, general & administrative expenses is $4.86 M
What is Achieve Life Sciences quarterly SG&A year-on-year change?
Over the past year, ACHV quarterly selling, general & administrative expenses has changed by +$1.87 M (+62.39%)
What is Achieve Life Sciences TTM selling, general & administrative expenses?
The current TTM SG&A of ACHV is -$711.92 M
What is the all time high TTM SG&A for Achieve Life Sciences?
Achieve Life Sciences all-time high TTM selling, general & administrative expenses is $13.63 M
What is Achieve Life Sciences TTM SG&A year-on-year change?
Over the past year, ACHV TTM selling, general & administrative expenses has changed by -$723.33 M (-6338.35%)